NorthCoast Asset Management LLC
Source: SEC Form 13F · as of Mar 2026NorthCoast Asset Management LLC holds 8 biotech & pharma companies tracked by BioSniper, totaling $10.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$10.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Incyte Corp. (INCY)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| INCYIncyte Corp. | 31,820 | $3.0M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 35,585 | $2.0M |
| ARGXARGENX SE | 2,034 | $1.5M |
| DRTSAlpha Tau Medical Ltd. | 147,138 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 5,738 | $800K |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 1,958 | $648K |
| EXELEXELIXIS, INC. | 14,885 | $638K |
| REGNREGENERON PHARMACEUTICALS, INC. | 757 | $585K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.